Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioengineered Exosome-Magnetic Nanoplatform for Precision Therapy of Hepatocellular Carcinoma <i>via</i> Dual-Targeted Drug Delivery.

International journal of nanomedicine·2026
Same author

Plasma membrane H<sup>+</sup>-ATPase Pma1 regulates growth and virulence in Penicillium digitatum from citrus fruits involving iron homeostasis.

Food microbiology·2026
Same author

Multi-omics profiling reveals systemic rejuvenation of the aged kidney through senolytic therapy.

NPJ Regenerative medicine·2026
Same author

Functional properties and Pickering emulsion stability of whey protein isolate-inulin complexes enhanced by covalent modification of proanthocyanidins.

Journal of the science of food and agriculture·2026
Same author

Targeting PCSK9 in Vascular Smooth Muscle Cells: An Effective Strategy to Suppress Ferroptosis and Attenuate Abdominal Aortic Aneurysm Progression.

Cell proliferation·2026
Same author

PROTAC-mediated PCSK9 degradation attenuates atherosclerosis and improves plaque composition via suppression of NF-κB/TNF-α pathway.

BMC medicine·2026

Related Experiment Video

Updated: Sep 8, 2025

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

10.3K

Three-Dimensional Physical Model in Urologic Cancer.

Yu Xie1,2, Guanlin Wu3, Yu Liang1

  • 1Department of Urology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University and the Clinical Research Center for Renal Tumor in Hunan Province, Changsha, China.

Frontiers in Surgery
|June 13, 2022
PubMed
Summary

Three-dimensional (3D) printing creates precise, patient-specific models for urologic cancer care. This review explores 3D printing applications, benefits, and challenges in urologic oncology, guiding future research.

Keywords:
patient counselingsurgical educationsurgical planning and simulationthree-dimensional printing (3D printing)urologic cancer

More Related Videos

Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
11:34

Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice

Published on: February 18, 2017

8.8K
3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

9.1K

Related Experiment Videos

Last Updated: Sep 8, 2025

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

10.3K
Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
11:34

Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice

Published on: February 18, 2017

8.8K
3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

9.1K

Area of Science:

  • Urologic Oncology
  • Medical Technology
  • 3D Printing Applications

Background:

  • Three-dimensional (3D) printing technology allows for high-precision, patient-specific physical models.
  • Its application is rapidly expanding in clinical practices, particularly within urologic cancer care.
  • A comprehensive understanding of its role, benefits, and challenges in urologic oncology is increasingly necessary.

Purpose of the Study:

  • To review recent studies on 3D printing in urologic cancer.
  • To identify and clarify the diverse applications of 3D-printed models.
  • To evaluate the benefits and challenges of integrating 3D printing into clinical practice.

Main Methods:

  • Mini-review of recently published literature.
  • Focus on studies detailing applications, feasibility, simulated organs, outcomes, and challenges.
  • Synthesis of current research on 3D printing in urologic cancer.

Main Results:

  • 3D-printed models are utilized for patient and trainee education, surgical simulation, and pre-operative planning/guidance.
  • Studies demonstrate the feasibility of procedures using these models.
  • The review highlights various application outcomes and inherent challenges in urologic cancer treatment.

Conclusions:

  • Three-dimensional printing offers significant potential in urologic cancer management.
  • Further research is needed to optimize its use and address existing challenges.
  • This technology can enhance surgical precision, training, and patient outcomes in urologic oncology.